Revenue and net profit dropped sharply year-over-year due to a high base and market challenges, but operating cash flow improved. Management is focusing on reagent sales, cost control, and efficiency, with strategic adjustments in both domestic and international markets.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.